Transplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousBone Marrow TransplantationTransplantation ConditioningStem Cell TransplantationLiver TransplantationHematopoietic Stem Cell MobilizationStem CellsMultiple MyelomaAntigens, CD34Graft SurvivalKidney TransplantationPeripheral Blood Stem Cell TransplantationMelphalanTreatment OutcomeHematopoiesisGraft vs Host DiseaseCell TransplantationCombined Modality TherapyWhole-Body IrradiationGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinSalvage TherapyHeart TransplantationBone Marrow PurgingRecurrenceHematologic NeoplasmsLeukapheresisBone Marrow CellsLung TransplantationCarmustineCyclophosphamideBone MarrowColony-Forming Units AssayRemission InductionAntineoplastic Combined Chemotherapy ProtocolsBusulfanRetrospective StudiesTissue DonorsTransplantation ChimeraDisease-Free SurvivalSurvival AnalysisTime FactorsCell DifferentiationOrgan TransplantationCells, CulturedCell SeparationEtoposideImmunosuppressive AgentsHodgkin DiseaseSurvival RateFlow CytometryGraft RejectionBlood Transfusion, AutologousMyeloablative AgonistsCord Blood Stem Cell TransplantationTransplantation ImmunologyCell LineageCytarabineGraft vs Tumor EffectTransplantationFollow-Up StudiesLeukemiaPancreas TransplantationIslets of Langerhans TransplantationGenetic TherapyMice, Inbred C57BLLentivirusTransduction, GeneticTransplantation, IsogeneicGenetic VectorsStem Cell NicheMyelodysplastic SyndromesLeukemia, Myeloid, AcuteKanamycin KinaseMesenchymal Stem Cell TransplantationThalidomideBlood Cell CountHistocompatibility TestingAntigens, CDBlood Component RemovalAdult Stem CellsFetal BloodPrognosisCell Culture TechniquesFeasibility StudiesLymphomaNeoplasm, ResidualVincristineImmunomagnetic SeparationNeoplastic Stem CellsLiving DonorsTransplantation, HeterologousAntineoplastic Agents, AlkylatingIdarubicinHistocompatibilityMice, SCIDTransplantation, Heterotopic